000 | 01082 a2200301 4500 | ||
---|---|---|---|
005 | 20250514004545.0 | ||
264 | 0 | _c20010816 | |
008 | 200108s 0 0 eng d | ||
022 | _a0887-6924 | ||
024 | 7 |
_a10.1038/sj.leu.2402193 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHassan, Z | |
245 | 0 | 0 |
_aThe pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro. _h[electronic resource] |
260 |
_bLeukemia _cAug 2001 |
||
300 |
_a1240-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xpharmacokinetics |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBusulfan _xpharmacokinetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes _xdrug effects |
650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aHassan, M | |
700 | 1 | _aHellström-Lindberg, E | |
773 | 0 |
_tLeukemia _gvol. 15 _gno. 8 _gp. 1240-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2402193 _zAvailable from publisher's website |
999 |
_c11407665 _d11407665 |